Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic’s many resources and see jobs available for medical professionals. Get updates.
Give to Mayo ClinicHelp set a new world standard in care for people everywhere. Give now.
Researchers are studying molecular sensitizing strategies that may help improve the efficacy of temozolomide in patients with newly diagnosed glioblastoma multiforme.
This project studies critical parameters that influence the efficacy of AAT combination regimens to improve outcomes in recurrent glioblastoma multiforme.
Researchers ultimately hope to translate findings into novel strategies that could significantly enhance the efficacy of therapy for typical glioblastoma multiforme tumors.
This project focuses on investigating two distinct mechanisms of temozolomide resistance emergence using patient-derived xenograft models and patient tumor tissues.
Researchers within Mayo Clinic and from around the country collaborate with the lab.
Mayo Clinic is a not-for-profit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.